Cargando…

Itolizumab in Psoriasis

A number of biologics is being used for the treatment of psoriasis. Itolizumab is one such agent which has been approved in India. It is an anti-CD6 monoclonal antibody that acts by binding to scavenger receptor cysteine-rich (SRCR) distal domain 1 of CD6. Itolizumab has been found to be safe, with...

Descripción completa

Detalles Bibliográficos
Autor principal: Srivastava, Ankita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527725/
https://www.ncbi.nlm.nih.gov/pubmed/28794555
http://dx.doi.org/10.4103/ijd.IJD_467_16